Remove 2022 Remove Competition Remove Healthcare Remove Specialization
article thumbnail

Competition is on the horizon for costly narcolepsy treatments

pharmaphorum

But increased competition is on the horizon. In order to bring it to market, a special program called Risk Evaluation and Mitigation Strategy (REMS) had to be put in place, where only eligible patients could access the drug through a very strict process. Competition starts to heat up. Classic treatment options. About the author.

article thumbnail

Is it Time for a New Healthcare Brand – Or a Rebrand?

Healthcare Success

Did your business neglect to establish proper healthcare branding from the beginning? Most brands evolve every three to ten years, but healthcare rebranding doesn’t have to be scary or daunting. Today’s healthcare businesses face new and aggressive competition on multiple fronts.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

It’s Time for Healthcare To Embrace Patient-Friendly Language

MedCity News

Increasingly, it’s a competitive differentiator – and it can help drive clinical improvements. Access and accessibility aren’t the same All three regulations have good intentions, but they unfortunately demonstrate an all-too-familiar refrain in healthcare. The message here is clear: Patients need to know what they’re paying for.

Patients 109
article thumbnail

Five IDNs to watch in 2023

Clarivate

In a fiercely competitive U.S. healthcare provision landscape, integrated delivery networks, or IDNs, are differentiating their offerings by adding outpatient treatment centers, pursuing National Cancer Institute designations and investing in value-based care. Christopher Silva, Senior Healthcare Research Analyst.

article thumbnail

Pharma Injecting Life into Digital Health Amidst Funding Downturn

MedCity News

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 106
article thumbnail

Nine for 2023, part one: a reflection on inflection

pharmaphorum

In some ways, it is not difficult to understand why: healthcare faced unprecedented challenge from the COVID-19 pandemic and responded in an extraordinary way. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

article thumbnail

The Top 10 Clinical Research Companies in the USA

Medico Reach

To bring effective medicines and Innovations in healthcare industry , a Clinical Research Organization or Contract Research Organization (CRO) are a must for the Biotech, Medtech, and pharma industries. In 2022, the global clinical research market stands at $63.6 from 2022 to 2027. from 2022 to 2027.